AGT and Hypertension: To determine whether suppression of miR-21 could prevent hypertension-induced cardiac alterations at different ages, using Ang II micropumps, we further established hypertensive models in young (12 week-old) and aged (50 week-old) miR-21−/− mice compared with the control (Figure 3A).